Jim Simons Royalty Pharma PLC Transaction History
Renaissance Technologies LLC
- $63.6 Billion
- Q1 2024
A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Royalty Pharma PLC stock. As of the latest transaction made, Renaissance Technologies LLC holds 10,190 shares of RPRX stock, worth $274,111. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,190Holding current value
$274,111% of portfolio
0.0%Shares
10 transactions
Others Institutions Holding RPRX
# of Institutions
395Shares Held
275MCall Options Held
276KPut Options Held
236K-
Morgan Stanley New York, NY44.2MShares$1.19 Billion0.11% of portfolio
-
Vanguard Group Inc Valley Forge, PA37.7MShares$1.01 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY21.2MShares$570 Million0.02% of portfolio
-
Baillie Gifford & CO16.7MShares$448 Million0.4% of portfolio
-
Viking Global Investors LP11.5MShares$309 Million1.33% of portfolio
About Royalty Pharma plc
- Ticker RPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 437,139,008
- Market Cap $11.8B
- Description
- Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...